Trial Profile
Proof-of-concept trial of BCI 838 for treatment-resistant major depressive disorder.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2012
Price :
$35
*
At a glance
- Drugs BCI 838 (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 14 Dec 2012 New trial record